Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 12, 2026 · Filed Nov 12, 2026
A major shareholder of Abcellera Biologics paid $699K out of pocket for Abcellera Biologics shares. 1 other person at Abcellera Biologics bought some too, in the same month. It was the first purchase in 20 months.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Written by software from the filings listed below · Nov 13, 2026
5 more points, with the facts they come from, are in OQRO Pro.
Sign up freeopen market purchase
Code P — open-market or private purchase
~$698,920
Shares × reported transaction price
$500K–$1M
+0.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 20 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 1 earlier confirmed purchase
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
3 days after results of Nov 9, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $11.62 on Nov 12, 2026, 318% above its 52-week low and 22% below its high, after a 16% drop over the previous 30 trading days
52-week range $2.78 (Feb 5, 2026) to $14.82 (Sep 29, 2026), 73% of the way up, from 250 adjusted closes. 30 trading days earlier: $13.91 on Oct 1, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The first open-market purchase by any ABCL insider since Mar 2025
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Insider filing
Traded Nov 13 · filed the same day
Gift or transfer — classified separately from trades.
Fund moves
From a 13F filed Nov 13, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Insider buying
First buy since 2023Traded Nov 13 · filed the same day
The CFO of Abcellera Biologics paid $97K out of pocket for Abcellera Biologics shares. 1 other person at Abcellera Biologics bought some too, in the same month. It was the first purchase in over a year.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
